Wendy S. Johnson

Wendy S. Johnson is Chief Development Officer at Reneo Pharmaceuticals, Inc. (RPHM). They have made 3 open-market trades across 3 companies since 2015, most recently 2021-09-03.

CIK 0001652822

Get an email the next time Wendy S. Johnson files.Follow for free

2 open-market purchases totalling $18K since 2015, against 1 sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
RPHM	111,736	$203K
XGN	1,000	$8K
APHB	1,000	$4K
Total		$216K

Shares reported on the most recent Form 4, priced at the 2021-09-07 close.

Grade by Ticker

CXGN

awaiting returns

Get an email the next time Wendy S. Johnson files

Free account. One email when the next filing comes in.

Follow Wendy S. Johnson for free

Buy Track Record

Filings2

Only 2 discretionary filings — too few to score

Discretionary filings only. 10b5-1 plan trades, tax withholding and option exercises are excluded, and each column is one row per filing rather than per execution lot.

Sell Track Record

Filings1

No scored decision-sell filings

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.

Volume by Type

SOpen-Market Sale

$950K

1 filings

MOption Exercise

$220K

1 filings

POpen-Market Purchase

$18K

2 filings

Companies

Trade History

3 total

XGNBUY

$14K

2021-09-037d: +8.5%

Opportunistic BuyFirst-Time Buyer

•Stock down -32% in previous 3 months

APHBBUY

$4K

2015-10-057d: -29.1%

Opportunistic BuyFirst-Time BuyerTop Trade

Ticker	Type	Traded	Filed	Price	Value	7d Stock	30d Stock	90d Stock
XGN	BUY	2021-09-03	2021-09-07	$14.02	$14K	+8.5%	-2.8%	-32.6%
RPHM	SELL	2021-07-14	2021-07-15	$8.50	$950K	+1.5%	-5.4%	-23.9%
APHB	BUY	2015-10-05	2015-10-07	$4.43	$4K	-29.1%	+3.0%	+0.5%

Related Insiders

Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.